Xanadu Quantum (XNDU) Stock: Secures $140M Funding as Q3 Net Loss Widens to $32.2 Million

TLDR

• Xanadu secures $140 million in Canadian funding to expand its Toronto facility.
• XNDU reports a $32.2 million Q3 net loss despite 32% revenue growth to $1.3 million.
• Research expenses jump 67% to $25.6 million as Xanadu expands quantum development.
• Xanadu ends September with $286.5 million in cash amid higher quarterly costs.
• AMD collaboration supports Xanadu’s push toward 1,000-plus logical qubits by 2031.

Xanadu Quantum Technologies (XNDU) secured $140 million in Canadian government funding despite reporting a wider third-quarter net loss of $32.2 million. The company reported higher revenue, but rising research and administrative costs weighed on its financial performance. Meanwhile, XNDU shares closed 0.72% higher at $2.80 before falling 6.79% to $2.61 in after-hours trading.

Xanadu Quantum Technologies Limited, XNDU

Xanadu Quantum Secures $140 Million in Canadian Government Funding

Xanadu Quantum secured approximately $140 million through Canada’s Strategic Response Fund to support its expanding quantum computing operations. The funding comes through a non-dilutive loan agreement supporting the company’s planned Inception facility in Toronto. Moreover, the government will reimburse qualifying research and development expenses as Xanadu advances construction and technology development.

The planned facility will cover 158,000 square feet and support advanced photonics research, manufacturing, and development. Additionally, Xanadu received provisional approval for up to $10 million through DARPA’s Quantum Benchmarking Initiative. The one-year extension will support further research into components required for fault-tolerant quantum computing systems.

The company continues expanding its manufacturing partnerships to improve hardware performance and reduce optical losses. Its collaboration with ASML targets waveguide losses, while GlobalFoundries will help scale silicon nitride technology and photon detectors. Meanwhile, Bluefors will develop compact cryogenic systems to reduce cooling requirements and support future quantum data centers.

Xanadu Quantum Q3 Net Loss Widens Despite Revenue Growth

Xanadu Quantum reported third-quarter revenue of $1.3 million, representing a 32% increase from the previous year. Revenue growth came primarily from DARPA contracts and commercial partnerships, although completed contracts offset some gains. However, higher operating expenses contributed to a wider quarterly net loss of $32.2 million, compared with $20.3 million previously.

Research and development expenses increased 67% year over year to $25.6 million during the quarter. Meanwhile, general and administrative expenses climbed 129% to $9.2 million as staffing and compensation costs increased. Consequently, adjusted EBITDA losses widened to $26.3 million from $15.4 million in the corresponding 2025 period.

Xanadu ended September with $286.5 million in cash and cash equivalents, supporting its ongoing development programs. Capital expenditures reached $8.4 million, primarily reflecting purchases of research and testing equipment. Separately, the company launched Backline with AMD to improve real-time communication between quantum hardware and classical computing systems.

Xanadu Quantum Advances Roadmap Toward 1,000 Logical Qubits

Xanadu Quantum continues developing photonic quantum computing technology, which uses light to process quantum information. The company recently introduced a seven-millidecibel optical switch as part of its broader effort to reduce system losses. Furthermore, its technology roadmap targets 200 logical qubits by 2029 and 500 logical qubits by 2030.

The company aims to exceed 1,000 logical qubits by 2031 as its manufacturing capabilities expand. Its Backline software demonstrated communication latency of 2.3 microseconds between an FPGA and CPU. Meanwhile, FPGA-to-GPU communication reached 4.5 microseconds, supporting faster processing and quantum error correction.

Xanadu also expanded research partnerships with Mitsubishi Chemical, Royal Bank of Canada, and the University of Alberta. These collaborations cover semiconductor materials, workforce development, and quantum algorithms for cancer treatment. Overall, the company’s latest results highlight expanding technical operations alongside rising costs and continued government support.

The post Xanadu Quantum (XNDU) Stock: Secures $140M Funding as Q3 Net Loss Widens to $32.2 Million appeared first on Blockonomi.